News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Genes to Therapies: One Year Later

In just its first year of operation, Cure Alzheimer’s Fund’s ambitious new Genes to Therapies™ (G2T) research program has bloomed far beyond expectations.

“We’re firing on all cylinders now,” says Research Consortium Chair Dr. Rudy Tanzi. “It’s exactly where we need to be headed to stop this disease.”

U.S. Government Increases Support of Alzheimer’s Research

Cure Alzheimer's Fund is very appreciative of the continuing commitment of Congress and President Obama reaffirmed by the approval of increased funding for Alzheimer's disease research. The additional $350 million for NIH included in the tax and spending bill signed into law is a tremendous step toward the $2 billion a year experts, including members of the Cure Alzheimer's Fund Research Consortium, have said is necessary to effectively treat or prevent Alzheimer's disease by 2025.

Drs. Rudy Tanzi and Doo Yeon Kim Receive Smithsonian Ingenuity Award

Cure Alzheimer’s Fund is thrilled to extend our congratulations to the chair of our Research Consortium, Dr. Rudy Tanzi, and to Dr. Doo Yeon Kim, for receiving the prestigious Smithsonian Magazine American Ingenuity Award.

Featured Researcher: David Michael Holtzman, M.D.

 

Welcoming Four New Renowned Scientists to Our Team

As our research “bench” continues to grow, we’re thrilled to welcome two new Research Consortium and two new Scientific Advisory Board members to our team. Each member brings unique expertise to accelerate our progress toward a cure.

 

Continued Growth Puts Focus on Research

With 10 years of research behind us, Cure Alzheimer’s Fund continues to grow, with the quality of our research remaining extraordinary. To build on our success, we recently welcomed four new Research Consortium members and four new employees to our organization.

New Insights Into the Blood-Brain Barrier

Three recent discoveries have clarified one of the least-understood elements of Alzheimer’s disease: how the blood-brain barrier becomes compromised and contributes to the disease process.

Featured Researcher: Berislav V. Zlokovic, M.D., Ph.D.

Born in Belgrade, “Betza” Zlokovic grew up an only child with a passion for the arts. Only one thing could lure this Renaissance man from the stage—his devotion to science.

21st Century Cures Act Passes House of Representatives

Cure Alzheimer's Fund is pleased to see the passage of the 21st Centuries Cures Act in the House of Representatives. The overwhelming bipartisan support for the bill shows the need for legislation to improve the process of getting to cures for life-threatening diseases like Alzheimer's.

House Appropriations Committee Proposes Significant Increase in Alzheimer's Research Funding

Cure Alzheimer's Fund is extremely happy with the House Appropriations Subcommittee bill for the National Institutes of Health (NIH) that was released today.